This is a news story, published by CityNews, that relates primarily to Rob Cribb news.
For more Rob Cribb news, you can click here:
more Rob Cribb newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CityNews, you can click here:
more news from CityNewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
clinical drug trial. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest private clinical trials news, Health Canada news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
clinical drug trialsCityNews
•
68% Informative
Being a part of a clinical drug trial can pay very well—up to several thousand dollars .
Many people need that cash and are desperate to participate.
Rob Cribb is the director of the Investigative Journalism Bureau at the Toronto Star .
When someone’s desperate for that money, they’ll cut many corners: lie to be accepted, fail to report adverse reactions.
VR Score
54
Informative language
42
Neutral language
67
Article tone
informal
Language
English
Language complexity
46
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
5
Source diversity
5
Affiliate links
no affiliate links